[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-336175-105":59,"doc-detail-336175-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","conserved-methylation-signatures-associate-with-the-tumor-immune-microenvironment-and-immunotherapy-response","Conserved methylation signatures associate with the tumor immune microenvironment and immunotherapy response","","Aberrant DNA methylation is a hallmark of cancer genomes, but the biological processes that shape epigenetic reprogramming and determine variants in the cancer methylome remain unclear, as do their links to cancer phenotypes. This study analyzes genome-wide methylation profiles from TCGA and defines conserved differentially methylated positions. It then derives independent methylation signatures using nonnegative matrix factorization, correlates them with clinical and immune microenvironment traits, infers determinant genes via integrative genomic and transcriptomic data, and evaluates effects in independent bulk and single-cell cohorts.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/conserved-methylation-signatures-associate-with-the-tumor-immune-microenvironment-and-immunotherapy-response/336175/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/conserved-methylation-signatures-associate-with-the-tumor-immune-microenvironment-and-immunotherapy-response/336175.png","ImageObject",300,407,{"name":92,"@type":93},"Lucas Martin","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-29","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":52},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What biological question does the study address about cancer DNA methylation?","Question",{"text":112,"@type":113},"The study asks which biological processes govern epigenetic reprogramming in cancer and how those processes influence variants in the cancer methylome that relate to cancer phenotypes.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How were conserved differentially methylated positions (DMPs) and methylation signatures derived?",{"text":117,"@type":113},"Conserved DMPs were defined using pairwise permutations across paired cancer and matched normal methylation profiles from TCGA. Independent methylation signatures were then extracted from cancer-only TCGA profiles and additional cell line data using nonnegative matrix factorization.",{"name":119,"@type":110,"acceptedAnswer":120},"What is the significance of the Hypo-MS4 methylation signature?",{"text":121,"@type":113},"Hypo-MS4 activity predicts poor survival and is associated with immunotherapy response and distant tumor metastasis, and it relates to TP53 mutation and FOXA1 binding specificity.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},336175,1790528403,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":52,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},8796095360427,"https://ap-avatar.wpscdn.com/davatar_994ba38a5ba835b3df7d355c54d3ed8d","Qin et al. Genome Medicine (2024) 16:47 [https://doi.org/10.1186/s13073-024-01318-3](https://doi.org/10.1186/s13073-024-01318-3)  \nGenome Medicine  \n RESEARCH Open Access  \nConserved methylation signatures associate   with the tumor immune microenvironment and immunotherapy response  \nQingqing Qin1,2,3†, Ying Zhou1,2,3†, Jintao Guo1,2,3, Qinwei Chen1,2, Weiwei Tang4,5, Yuchen Li 1,2,3, Jun You6 and Qiyuan Li 1,2,3*  \nAbstract  \nBackground Aberrant DNA methylation is a major characteristic of cancer genomes. It remains unclear which biological processes determine epigenetic reprogramming and how these processes influence the variants in the cancer methylome, which can further impact cancer phenotypes.  \nMethods We performed pairwise permutations of 381,900 loci in 569 paired DNA methylation profiles of cancer tissue and matched normal tissue from The Cancer Genome Atlas (TCGA) and defined conserved differentiallymethylated positions (DMPs) based on the resulting null distribution. Then, we derived independent methylation signatures from 2,465 cancer-only methylation profiles from theTCGA and 241 cell line-based methylation profiles from the Genomics of Drug Sensitivity in Cancer (GDSC) cohort using nonnegative matrix factorization (NMF) . We correlated DNA methylation signatures with various clinical and biological features, including age, survival, cancer stage, tumor immune microenvironment factors, and immunotherapy response. We inferred the determinant genes of these methylation signatures by integrating genomic and transcriptomic data and evaluated the impact of these signatures on cancer phenotypes in independent bulk and single-cell RNA/methylome cohorts.  \nResults We identified 7,364 differentially methylated positions (2,969 Hyper-DMPs and 4,395 Hypo-DMPs) in nine cancer types from theTCGA. We subsequently retrieved three highly conserved, independent methylation signatures (Hyper-MS1, Hypo-MS1, and Hypo-MS4) from cancer tissues and cell lines based on these Hyper and Hypo-DMPs. Our data suggested that Hypo-MS4 activity predicts poor survival and is associated with immunotherapy response and distant tumor metastasis, and Hypo-MS4 activity is related to TP53 mutation and FOXA1 binding specificity. In addition, we demonstrated a correlation between the activities of Hypo-MS4 in cancer cells and the fractions of regulatory CD4 + T cells with the expression levels of immunological genes in the tumor immune microenvironment. Conclusions Our findings demonstrated that the methylation signatures of distinct biological processes are associated with immune activity in the cancer microenvironment and predict immunotherapy response.  \nKeywords DNA methylation signature, Determinant genes, DNA-binding motifs, Immunotherapy response  \n†Qingqing Qin andYing Zhou contributed equally to this work.  \n*Correspondence: Qiyuan Li [qiyuan.li@xmu.edu.cn](qiyuan.li@xmu.edu.cn)  \nFull list of author information is available at the end of the article  \n© The Author(s) 2024. Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit [http://creativecommons.org/licenses/by/4.0/](http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver ()[. The Creative Commons Public Domai","cbCaikvQHJGyTmxs","https://ap.wps.com/l/cbCaikvQHJGyTmxs","pdf",69601430,17,"English","# Background\n## Aberrant cancer methylation and phenotypic impact\n## Methylation regulation and genetic/epigenetic factors\n# Methods\n## Permutation-based identification of conserved DMPs\n## Signature discovery via nonnegative matrix factorization\n## Association with clinical, biological, and immune features\n## Determinant gene inference and validation cohorts\n# Results\n## Conserved differentially methylated positions across cancer types\n## Independent conserved methylation signatures (Hyper-MS1, Hypo-MS1, Hypo-MS4)\n## Prognostic and immunotherapy-response associations for Hypo-MS4\n# Conclusions\n## Methylation signatures link immune activity to immunotherapy response","[{\"question\":\"What biological question does the study address about cancer DNA methylation?\",\"answer\":\"The study asks which biological processes govern epigenetic reprogramming in cancer and how those processes influence variants in the cancer methylome that relate to cancer phenotypes.\"},{\"question\":\"How were conserved differentially methylated positions (DMPs) and methylation signatures derived?\",\"answer\":\"Conserved DMPs were defined using pairwise permutations across paired cancer and matched normal methylation profiles from TCGA. Independent methylation signatures were then extracted from cancer-only TCGA profiles and additional cell line data using nonnegative matrix factorization.\"},{\"question\":\"What is the significance of the Hypo-MS4 methylation signature?\",\"answer\":\"Hypo-MS4 activity predicts poor survival and is associated with immunotherapy response and distant tumor metastasis, and it relates to TP53 mutation and FOXA1 binding specificity.\"}]","Conserved methylation signatures associate with the tumor immune microenvironment and immunotherapy response | PDF",1790013982,43,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e196b16921c7a29c7f3dcddfbd1715a2.webp",983,1305,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/70db42bc46c419f6299baa3fc6da3136.webp",982,1304,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/740292a7ab4b81f9664ecdf110e12bdc.webp",981,1303,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b513193b3956d4faf8d76cc802b076a6.webp",980,1301]